Why the study?
A novel N-terminal truncated MMP-2 isoform (NTT-MMP-2) generated during oxidative stress was shown to induce severe systolic failure, but the underlying injury mechanisms remained unclear.
Answers are grounded in this paper and cite their sources.
NTT-MMP-2 impairs contractility via Ca2+ handling in mice; extends isoform-specific MMP-2 mechanisms but leaves open human HF relevance.
UNLABELLED: The full-length isoform of matrixmetalloproteinase-2 (FL-MMP-2) plays a role in turnover of the cardiac extracellular matrix. FL-MMP-2 is also present intracellularly in association with sarcomeres and, in the setting of oxidative stress, cleaves myofilament proteins with resultant impaired contractility. Recently, a novel N-terminal truncated MMP-2 isoform (NTT-MMP-2) generated during oxidative stress was identified and shown to induce severe systolic failure; however, the injury mechanisms remained unclear. In this study, cardiac-specific NTT-MMP-2 transgenic mice were used to determine the physiological effects of NTT-MMP-2 on: force development of intact myocardium; the function of cardiac myofilaments in demembranated myocardium; and on intracellular Ca(2+) transients in isolated myocytes. We related the contractile defects arising from NTT-MMP-2 expression to the known intracellular locations of NTT-MMP-2 determined using immunohistochemistry. Comparison was made with the pathophysiology arising from cardiac-specific FL-MMP-2 transgenic mice. Consistent with previous studies, FL-MMP-2 was localized to myofilaments, while NTT-MMP-2 was concentrated within subsarcolemmal mitochondria and to sites in register with the Z-line. NTT-MMP-2 expression caused a 50% reduction of force development by intact myocardium. However, NTT-MMP-2 expression did not reduce myofilament force development, consistent with the lack of NTT-MMP-2 localization to myofilaments. NTT-MMP-2 expression caused a 50% reduction in the amplitude of Ca(2+) transients, indicating impaired activation. CONCLUSIONS: Unlike FL-MMP-2, NTT-MMP-2 does not mediate myofilament damage. Instead, NTT-MMP-2 causes impaired myocyte activation, which may involve effects due to localization in mitochondria and/or to transverse tubules affecting Ca(2+) transients. Thus, FL-MMP-2 and NTT-MMP-2 have discrete intracellular locations and mediate different intracellular damage to cardiac myocytes.
No takes yet. Share an insight, caveat, or question.
Lovett et al. (2014) studied Cardiac contractile dysfunction / Systolic heart failure (n=17). Cardiac-specific N-terminal truncated MMP-2 (NTT-MMP-2) transgenic expression vs. Wild-type littermate control mice (and FL-MMP-2 transgenic mice) was evaluated on Force development by intact myocardium and amplitude of intracellular Ca2+ transients in isolated myocytes (50% reduction in intact myocardial force and Ca2+ transient amplitude, p=<0.001).
Synapse has enriched 10 related papers. Consider them for comparative context: